People who give blood or other tissues for research should be able to track their use through the scientific process to see the data their activities or samples generate, Harvard University scientists said.
The $14.5 billion investment by the U.S. in the Human Genome Project, completed a decade ago, has paid off more than 60-fold in new jobs, drugs and a rapidly expanding genetics industry, an analysis has found.
The Wellcome Trust, the world’s second-biggest medical charity, said its investments returned 18 percent, or more than 2.6 billion pounds ($4.2 billion), in the year ended Sept. 30, aided by more exposure to public and private equity since 2008.
Almost a decade after the U.S. human genome project was completed, scientists say they have mapped the underlying regulatory system that switches DNA on and off, potentially spurring a wave of new research into the molecular basis of complex diseases such as Type 1 diabetes.
On the fourth floor of a red brick medical building in Boston’s South End is an office where few want to go -- where people get a frequently unwelcome glimpse of their future through a careful reading of their DNA.
Heidi Williams’s dad helped with her high school science-fair projects by driving her two hours from their North Dakota town to get books on World War II German cryptography. After studying up, she would present new ways to crack the cipher.
The U.S. Supreme Court restricted the ability of companies to patent human genetic sequences, issuing a mixed ruling in a case that raised questions about thousands of biotechnology, agricultural and drug patents.